 |
|
Prostate Cancer - Featured Clinical Trials
The following list shows Featured Clinical Trials for a specific type of cancer. You may also want to view:
11. Combination Therapy for High-Risk Prostate Cancer
(Posted: 12/05/2006) - In this trial, after initial radiation and hormone therapy, men with localized, high-risk, androgen-responsive prostate cancer will be treated with the drugs docetaxel and prednisone.
12. Prostate Cancer Vaccine Trial
(Posted: 10/03/2006) - In this clinical trial, researchers are testing a new type of vaccine therapy in patients with prostate cancer that has recurred locally or progressed following previous treatment.
13. Targeted Therapy for Metastatic Prostate Cancer
(Posted: 06/20/2006) - This trial is evaluating the addition of two targeted therapies, bevacizumab and thalidomide, to chemotherapy with docetaxel and prednisone for patients with androgen-independent, metastatic prostate cancer.
14. MRI-Guided Radiotherapy for Prostate Cancer
(Posted: 04/11/2006) - In this phase I trial, doctors will study the side effects and determine the best dose of a new treatment for localized prostate cancer called intensity-modulated external-beam radiation therapy.
15. Preventing Bone Fractures in Prostate Cancer Patients
(Posted: 09/07/2004, Updated: 02/28/2006) - This study will evaluate the ability of zoledronic acid (Zometa®), one of a family of drugs known as bisphosphonates, to prevent fractures and other bone complications when administered at the same time as or shortly following androgen deprivation therapy.
< Previous 1 2 3 4 Next >
|
|
|
